These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 12191973)
1. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. Gueler F; Rong S; Park JK; Fiebeler A; Menne J; Elger M; Mueller DN; Hampich F; Dechend R; Kunter U; Luft FC; Haller H J Am Soc Nephrol; 2002 Sep; 13(9):2288-98. PubMed ID: 12191973 [TBL] [Abstract][Full Text] [Related]
2. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403 [TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Usui H; Shikata K; Matsuda M; Okada S; Ogawa D; Yamashita T; Hida K; Satoh M; Wada J; Makino H Nephrol Dial Transplant; 2003 Feb; 18(2):265-72. PubMed ID: 12543879 [TBL] [Abstract][Full Text] [Related]
5. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion. Joyce M; Kelly C; Winter D; Chen G; Leahy A; Bouchier-Hayes D J Surg Res; 2001 Nov; 101(1):79-84. PubMed ID: 11676559 [TBL] [Abstract][Full Text] [Related]
7. alpha-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Jo SK; Yun SY; Chang KH; Cha DR; Cho WY; Kim HK; Won NH Nephrol Dial Transplant; 2001 Aug; 16(8):1583-91. PubMed ID: 11477159 [TBL] [Abstract][Full Text] [Related]
8. Opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury. Nakajima A; Ueda K; Takaoka M; Yoshimi Y; Matsumura Y J Pharmacol Exp Ther; 2006 Mar; 316(3):1038-46. PubMed ID: 16306274 [TBL] [Abstract][Full Text] [Related]
9. Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Chatterjee PK; Brown PA; Cuzzocrea S; Zacharowski K; Stewart KN; Mota-Filipe H; McDonald MC; Thiemermann C Kidney Int; 2001 Jun; 59(6):2073-83. PubMed ID: 11380809 [TBL] [Abstract][Full Text] [Related]
10. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744 [TBL] [Abstract][Full Text] [Related]
11. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2. Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498 [TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9. Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080 [TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Vartiainen N; Goldsteins G; Keksa-Goldsteine V; Chan PH; Koistinaho J Stroke; 2003 Mar; 34(3):752-7. PubMed ID: 12624303 [TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion. Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227 [TBL] [Abstract][Full Text] [Related]
16. Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure. Aravindan N; Natarajan M; Shaw AD J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):179-86. PubMed ID: 16616657 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy. Álvarez-Prats A; Hernández-Perera O; Díaz-Herrera P; Ucero ÁC; Anabitarte-Prieto A; Losada-Cabrera A; Ortiz A; Rodríguez-Pérez JC Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208 [TBL] [Abstract][Full Text] [Related]
18. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Dechend R; Fiebeler A; Park JK; Muller DN; Theuer J; Mervaala E; Bieringer M; Gulba D; Dietz R; Luft FC; Haller H Circulation; 2001 Jul; 104(5):576-81. PubMed ID: 11479256 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin improves the course of ischemic acute renal failure in aging rats. Sabbatini M; Pisani A; Uccello F; Serio V; Serù R; Paternò R; Cianciaruso B; Fuiano G; Andreucci M J Am Soc Nephrol; 2004 Apr; 15(4):901-9. PubMed ID: 15034092 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion. Xiong C; Zang X; Zhou X; Liu L; Masucci MV; Tang J; Li X; Liu N; Bayliss G; Zhao TC; Zhuang S Oncotarget; 2017 May; 8(19):31238-31253. PubMed ID: 28415724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]